Literature DB >> 18716738

Neuromuscular junctional disorders.

A S Girija1, V V Ashraf.   

Abstract

Neuromuscular junctional disorders (NMJ) in children are distinct entity. They may be acquired or hereditary. They pose problem in diagnosis because of the higher occurrence of sero negative Myasthenia Gravis (MG) cases in children. The identity of MusK antibody positivity in a good percentage of sero negative cases further adds to problems in diagnosis. The Congenital Myasthenic Syndrome (CMS) which are rare disorders of hereditary neuromuscular transmission (NMT) has to be differentiated because immunotherapy has no benefit in this group. Molecular genetic studies of these diseases helps to identify specific type of CMS which is important as other drugs like Fluoxetine, Quinidine are found to be effective in some. In infancy, all can manifest as floppy infant syndrome. The important key to diagnosis is by detailed electrophysiological studies including repetitive nerve stimulation at slow and high rates and its response to anticholinesterases and estimation of Acetyl choline receptor antibodies. Other causes of neuromuscular transmission defects viz. snake venom poisoning and that due to drugs are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716738     DOI: 10.1007/s12098-008-0132-4

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  13 in total

Review 1.  Congenital myasthenic syndrome: report of four cases and brief review of literature.

Authors:  G A Khwaja; D Chowdhury; M Gupta
Journal:  Neurol India       Date:  2000-09       Impact factor: 2.117

2.  Early-onset myasthenia gravis: clinical characteristics and response to therapy.

Authors:  A P Batocchi; A Evoli; M T Palmisani; M Lo Monaco; M Bartoccioni; P Tonali
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

Review 3.  Transient neonatal myasthenia gravis.

Authors:  O Papazian
Journal:  J Child Neurol       Date:  1992-04       Impact factor: 1.987

4.  A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.

Authors:  A G Engel; E H Lambert; M R Gomez
Journal:  Ann Neurol       Date:  1977-04       Impact factor: 10.422

5.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.

Authors:  W Hoch; J McConville; S Helms; J Newsom-Davis; A Melms; A Vincent
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 6.  Acetylcholine receptors and myasthenia.

Authors:  J M Lindstrom
Journal:  Muscle Nerve       Date:  2000-04       Impact factor: 3.217

7.  Myasthenia gravis in children: a longitudinal study.

Authors:  V V Ashraf; A B Taly; M Veerendrakumar; S Rao
Journal:  Acta Neurol Scand       Date:  2006-08       Impact factor: 3.209

8.  Neurophysiological evaluation in myasthenia gravis. A comprehensive study of a complete patient population.

Authors:  F E Somnier; W Trojaborg
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1993-04

9.  Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome.

Authors:  P Maddison; J Newsom-Davis; K R Mills
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

Review 10.  Congenital myasthenic syndromes.

Authors:  A G Engel
Journal:  Neurol Clin       Date:  1994-05       Impact factor: 3.806

View more
  1 in total

1.  COLQ-mutant Congenital Myasthenic Syndrome with Microcephaly: A Unique Case with Literature Review.

Authors:  Mohammad A Al-Muhaizea; Sulaiman Bazee Al-Mobarak
Journal:  Transl Neurosci       Date:  2017-07-20       Impact factor: 1.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.